Identifying Valid Algorithms for Number of Lines of Anti-Neoplastic Therapy in the Danish National Patient Registry Among Patients with Advanced Ovarian, Gastric, Renal Cell, Urothelial, and Non-Small Cell Lung Cancer Attending a Danish University Hospital

References

• Explanation of first-line and second-line chemotherapy regimens; 2021. Available from: https://callaix.com/firstline. Accessed September 2, 2021.
   Google Scholar
• Reck M, Popat S, Reinmuth N, et al. Metastatic non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25 Suppl 3:iii27–iii39. doi:10.1093/annonc/mdu199
   Web of Science ®Google Scholar
• Escudier B, Porta C, Schmidinger M, et al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v58–v68. doi:10.1093/annonc/mdw328
   PubMed Web of Science ®Google Scholar
• Davies J, Patel M, Gridelli C, de Marinis F, Waterkamp D, McCusker ME. Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: a systematic review of recently published studies. PLoS One. 2017;12(4):e0175679. doi:10.1371/journal.pone.0175679
   Web of Science ®Google Scholar
• Sacher AG, Le LW, Lau A, Earle CC, Leighl NB. Real-world chemotherapy treatment patterns in metastatic non-small cell lung cancer: are patients undertreated? Cancer. 2015;121(15):2562–2569. doi:10.1002/cncr.29386
   Web of Science ®Google Scholar
• Weymann D, Costa S, Regier DA. Validation of a cyclic algorithm to proxy number of lines of systemic cancer therapy using administrative data. JCO Clin Cancer Inform. 2019;3:1–10. doi:10.1200/CCI.19.00022
   Web of Science ®Google Scholar
• Carroll NM, Burniece KM, Holzman J, McQuillan DB, Plata A, Ritzwoller DP. Algorithm to identify systemic cancer therapy treatment using structured electronic data. JCO Clin Cancer Inform. 2017;1:1–9. doi:10.1200/CCI.17.00002
   Web of Science ®Google Scholar
• Palmaro A, Gauthier M, Despas F, Lapeyre-Mestre M. Identifying cancer drug regimens in French health insurance database: an application in multiple myeloma patients. Pharmacoepidemiol Drug Saf. 2017;26(12):1492–1499. doi:10.1002/pds.4266
   Web of Science ®Google Scholar
• Bikov KA, Mullins CD, Seal B, Onukwugha E, Hanna N. Algorithm for identifying chemotherapy/biological regimens for metastatic colon cancer in SEER-medicare. Med Care. 2015;53(8):E58–E64. doi:10.1097/MLR.0b013e31828fad9f
   Web of Science ®Google Scholar
• Di Lorenzo G, Buonerba C, Bellelli T, et al. Third-line chemotherapy for metastatic urothelial cancer: a Retrospective Observational Study. Medicine. 2015;94(51):e2297. doi:10.1097/MD.0000000000002297
   PubMed Web of Science ®Google Scholar
• Schonnemann KR, Mortensen MB, Bjerregaard JK, Fristrup C, Pfeiffer P. Characteristics, therapy and outcome in an unselected and prospectively registered cohort of patients with gastro-oesophageal cancer. Acta Oncol. 2014;53(3):385–391. doi:10.3109/0284186X.2013.820839
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish national patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S91125
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/CLEP.S179083
   PubMed Web of Science ®Google Scholar
• Gjerstorff ML. The Danish cancer registry. Scand J Public Health. 2011;39(7 Suppl):42–45. doi:10.1177/1403494810393562
   PubMed Web of Science ®Google Scholar
• Schmidt M, Pedersen L, Sorensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-3
   PubMed Web of Science ®Google Scholar
• Mainz J, Hess MH, Johnsen SP. The Danish unique personal identifier and the Danish civil registration system as a tool for research and quality improvement. Int J Qual Health Care. 2019;31(9):717–720. doi:10.1093/intqhc/mzz008
   PubMed Web of Science ®Google Scholar
• Compton CC, Byrd DR, Garcia-Aguilar J, Kurtzman SH, Olawaiye A, Washington MK. AJCC Cancer Staging Atlas. New York: Springer; 2012.
   Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381. doi:10.1016/j.jbi.2008.08.010
   PubMed Web of Science ®Google Scholar
• Ho GY, Woodward N, Coward JI. Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies. Crit Rev Oncol Hematol. 2016;102:37–46. doi:10.1016/j.critrevonc.2016.03.014
   PubMed Web of Science ®Google Scholar
• Brown LD, Cai TT, DasGupta A. Confidence intervals for a binomial proportion and asymptotic expansions. Ann Stat. 2002;30(1):160–201. doi:10.1214/aos/1015362189
   Web of Science ®Google Scholar
• Broe MO, Jensen PB, Mattsson TO, Pottegard A. Validity of antineoplastic procedure codes in the Danish national patient registry: the case of colorectal cancer. Epidemiology. 2020;31(4):599–603. doi:10.1097/EDE.0000000000001208
   PubMed Web of Science ®Google Scholar
• Probst HB, Hussain ZB, Andersen O. Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians–a national Danish project. Health Policy. 2012;105(1):65–70. doi:10.1016/j.healthpol.2011.11.001
   PubMed Web of Science ®Google Scholar
• Lund JL, Froslev T, Deleuran T, et al. Validity of the Danish national registry of patients for chemotherapy reporting among colorectal cancer patients is high. Clin Epidemiol. 2013;5:327–334. doi:10.2147/CLEP.S49773
   PubMedGoogle Scholar
• Sorup S, Darvalics B, Khalil AA, et al. Treatment and survival in advanced non-small cell lung cancer, urothelial, ovarian, gastric and kidney cancer: a nationwide comprehensive evaluation. Clin Epidemiol. 2021;13:871–882. doi:10.2147/CLEP.S326470
   Web of Science ®Google Scholar
• Vesteghem C, Brøndum RF, Falkmer UG, Pottegård A, Poulsen LØ, Bøgsted M. High validity of the Danish national patient registry for systemic anticancer treatment registration from 2009 to 2019. Clin Epidemiol. 2021;13:1085–1094. doi:10.2147/CLEP.S332776
   PubMed Web of Science ®Google Scholar